Ligand validation:4P00

C2E: 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)

C2E is a Ligand Of Interest in 4P00 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4P00_C2E_A_919	90%	44%	0.076	0.96	0.97	1.2	4	6	3	0	100%	1
4P00_C2E_A_920	84%	45%	0.077	0.939	0.96	1.15	3	5	13	0	100%	1
5EJ1_C2E_A_919	86%	3%	0.067	0.933	4.66	1.74	28	13	4	0	100%	1
4P02_C2E_A_918	83%	47%	0.112	0.97	0.96	1.07	2	5	0	0	100%	1
5EIY_C2E_A_920	75%	3%	0.131	0.964	4.58	1.61	30	14	3	0	100%	1
5EJZ_C2E_A_920	72%	48%	0.128	0.952	0.99	1.03	2	5	0	0	100%	1
8U0I_C2E_A_102	100%	40%	0.042	0.984	1.15	1.19	6	6	0	0	100%	1
4RT1_C2E_B_201	99%	17%	0.054	0.982	2.38	1.24	11	7	0	0	100%	1
4RT0_C2E_A_202	98%	13%	0.05	0.974	2.34	1.6	11	13	0	0	100%	1
4URG_C2E_A_1241	97%	16%	0.065	0.983	2.24	1.49	10	10	0	0	100%	1
5HTL_C2E_B_201	97%	17%	0.057	0.973	2.34	1.3	15	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.